3%±3.7% at 24 months. 3 stent fractures were noted, none were symptomatic. Mean quality of life (EQ5D-3L) was significantly improved at 24 months (71.2 ±20.3 vs. 52.4 ±22.6, p=0.001). Conclusions Our results showed that primary bare metal stenting for iliac CTO is safe and efficient at 24 months and could be considered as a first-line st…[Read more]